Derivative Liabilities

9 Months Ended

Aug. 31, 2015

Notes to Financial Statements

Derivative Liabilities

Note 10 - Derivative Liabilities

The Company evaluated its convertible note agreements pursuant to ASC 815 and for those notes in which there was no minimum or fixed conversion price resulting in an indeterminate number of shares to be issued in the future, the Company determined an embedded derivative existed and ASC 815 applied for its convertible notes. The Company valued the embedded derivatives using the Black-Scholes valuation model.  

Convertible debt with a variable conversion feature

In 2015, the Company estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.34 years; (2) a computed volatility rate of 422%; (3) a discount rate of 1%; and (4) zero dividends. Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

In 2014, the Company estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.34 years; (2) a computed volatility rate of 230%; (3) a discount rate of 1%; and (4) zero dividends. Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

Tainted conventional convertible debt

In 2015, the Company estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .0 to .534 years; (2) a computed volatility rate of 422%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

In 2014, the Company estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.34 years; (2) a computed volatility rate of 230%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

Tainted warrants

The Company also evaluated all outstanding warrants to determine whether these instruments may be tainted. All warrants outstanding were considered tainted as a result of the tainted equity environment and potential inability of the Company to settle the instruments with shares of the Company’s stock as the number of shares issuable cannot be estimated and could exceed the amount of authorized shares available to be issued by the Company. The Company valued the embedded derivatives within the warrants using the Black-Scholes valuation model.  

In 2015, the Company estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .46 to 7.83 years; (2) a computed volatility rate of 422%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

In 2014, the Company estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .25 to 8.83 years; (2) a computed volatility rate of 172%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

Activity for embedded derivative instruments during the six months ended August 31, 2015 was as follows:

	Balance at November 30, 2014		Initial valuation of derivative liabilities upon issuance of new securities during the period		Change in fair value of derivative liabilities			Conversion of debt to equity			Debt Forgiveness			Balance at August 31, 2015
Variable convertible debt	$	527,781	$	81,793	$	2,384,209		$	(1,488,450	)	$	(1,153,545	)	$	351,788
Tainted convertible debt		106,246		118,790		(82,025	)		—						143,011
Tainted warrants		5,312		2,000		21,917			—						29,229
	$	639,339	$	202,583	$	2,324,101		$	(1,488,450	)	$	(1,153,545	)	$	524,028

Activity for embedded derivative instruments during the nine months ended August 31, 2014 was as follows:

	Balance at November 30, 2013		Initial valuation of derivative liabilities upon issuance of new securities during the period		Change in fair value of derivative liabilities			Conversion of debt to equity			Balance at August 31, 2014
Variable convertible debt	$	1,467,182	$	230,837	$	(254,972	)	$	(300,920	)	$	1,142,126
Tainted convertible debt		139,953		—		(136,600	)		—			74
Tainted warrants		65,209		—		(22,899	)		—			8,969
	$	1,672,344	$	230,837	$	(451,091	)	$	(300,920	)	$	1,151,169